Elon Musk’s Neuralink seeks patients globally to try its brain chips

Neuralink's Clinical Trials: Elon Musk's Neuralink is recruiting quadriplegic patients globally for its clinical trial, allowing them to control computers with their thoughts through a brain implant. The ongoing PRIME study aims to explore the device's capabilities over six years.

Patient Experience and Future Aspirations: Noland Arbaugh, Neuralink's first patient, reports no side effects after a year of using the implant, which he uses extensively for various tasks. He expresses optimism about the technology's potential to enhance lives and mentions ongoing research to enable wheelchair control with the device.